A Dark Vector Cognition product

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

80K characters. Original on sec.gov ·

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The 15 tables in Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Third Quarter 2026 Overview

You should refer to "Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations - Factors Affecting Operating Results" in our Annual Report on Form 10-K for the year ended December 31, 2025, for a discussion of key factors affecting operating results in each of our business segments. In addition, you should refer to "Item 9A, Controls and Procedures" in our Annual Report on Form 10-K for the year ended December 31, 2025, and to "Item 4, Controls and Procedures" in this Quarterly Report on Form 10-Q for the period ended September 30, 2026, for a discussion of our internal controls over financial reporting.

Viterra Acquisition

On July 2, 2025, we completed our previously announced acquisition (the "Acquisition") of Viterra Limited ("Viterra"). Pursuant to the terms of the business combination agreement, Viterra shareholders received approximately 65.6 million registered shares of Bunge, with an aggregate value of approximately $5.3 billion as of July 2, 2025, and approximately $1.9 billion in cash, in return for 100% of the outstanding equity of Viterra.

This section is inclusive of the results of operations of Viterra from the date of Acquisition. As such, the Acquisition of Viterra is frequently one of the primary drivers of the year-over-year variances for the year-to-date results discussed throughout this section.

Non-U.S. GAAP Financial Measures

Total earnings before interest and taxes ("EBIT") is an operating performance measure used by Bunge’s management to evaluate reportable segment operating activities as well as Corporate and Other results. Bunge also uses Segment EBIT, Corporate and Other EBIT, and Total EBIT to evaluate the operating performance of Bunge’s reportable segments and Total reportable segments together with Corporate and Other activities. Segment EBIT is the aggregate of the EBIT of each of Bunge’s Soybean Processing and Refining, Softseed Processing and Refining, Tropical Oils and Specialty Ingredients, and Grain Merchandising and Milling reportable segments. Total EBIT is the aggregate of the EBIT of Bunge’s reportable segments, together with Corporate and Other activities. Bunge’s management believes Segment EBIT, Corporate and Other EBIT, and Total EBIT are useful measures of operating profitability since the measures allow for an evaluation of performance without regard to financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total EBIT is a non-U.S. GAAP financial measure and is not intended to replace Net income (loss) attributable to Bunge shareholders, the most directly comparable U.S. GAAP financial measure. Further, Total EBIT excludes EBIT attributable to noncontrolling interests and EBIT attributable to discontinued operations and is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Net income (loss) attributable to Bunge shareholders to Total EBIT below.

Executive Summary

Net income (loss) attributable to Bunge shareholders - For the three months ended September 30, 2026, Net income attributable to Bunge shareholders was $318 million, an increase of $152 million compared to $166 million, for the three months ended September 30, 2025. For the nine months ended September 30, 2026, Net income attributable to Bunge shareholders was $1,064 million, an increase of $343 million, compared to $721 million for the nine months ended September 30, 2025. The increase for the three months ended September 30, 2026, was primarily due to higher Segment EBIT and Corporate and Other EBIT, as further described in the Segment Results section below, partially offset by higher income tax expense, as further described in the Consolidated Results of Operations section below. The increase for the nine months ended September 30, 2026, was primarily due to higher Segment EBIT, as further described in the Segment Results section below, partially offset by higher net interest expense as a result of increased debt levels to finance the Viterra Acquisition and fund working capital requirements, as well as higher income tax expense, as further described in the Consolidated Results of Operations section below.

Net income (loss) attributable to Bunge shareholders - Earnings per share - diluted - For the three months ended September 30, 2026, Net income attributable to Bunge shareholders - diluted, was $1.64 per share, an increase of $0.80 per share, compared to $0.84 per share for the three months ended September 30, 2025. For the nine months ended September 30, 2026, Net income attributable to Bunge shareholders - diluted, was $5.45 per share, an increase of $0.85 per share, compared to $4.60 per share for the nine months ended September 30, 2025. The increase for the three and nine months ended September 30, 2026 was primarily due to higher Net income (loss) attributable to Bunge shareholders discussed

above. Further, the increase for the nine months ended September 30, 2026, was partially offset by dilution from the issuance of registered shares as part of the Viterra Acquisition.

Total EBIT - For the three months ended September 30, 2026, Total EBIT was $667 million, an increase of $264 million compared to $403 million for the three months ended September 30, 2025. For the nine months ended September 30, 2026, Total EBIT was $1,911 million, an increase of $642 million compared to Total EBIT of $1,269 million for the nine months ended September 30, 2025. The increase in Total EBIT for the three months ended September 30, 2026, was primarily due to higher Segment EBIT, resulting primarily from more favorable results in our Soybean Processing and Refining and Softseed Processing and Refining segments, and higher Corporate and Other EBIT, resulting from lower Selling, general and administrative expenses. The increase was partially offset by less favorable results in our Grain Merchandising and Milling and Tropical Oils and Specialty Ingredients segments. The increase in Total EBIT for the nine months ended September 30, 2026, was primarily due to higher Segment EBIT, resulting primarily from more favorable results in our Soybean Processing and Refining and Softseed Processing and Refining segments, partially offset by less favorable results in our Grain Merchandising and Milling segment. The Segment Overview section below provides further details as well as a reconciliation of Net income attributable to Bunge shareholders to Total EBIT.

Liquidity and Capital Resources – At September 30, 2026, working capital, which equals Total current assets less Total current liabilities, was $9,774 million, a decrease of $848 million, compared to working capital of $10,622 million at September 30, 2025, and an increase of $510 million, compared to working capital of $9,264 million at December 31, 2025. The decrease in working capital at September 30, 2026, compared to September 30, 2025, was primarily due to higher Short-term debt and Trade accounts payable balances, as well as lower Cash and cash equivalents and Other current assets, partially offset by higher Inventories. The increase in working capital at September 30, 2026, compared to December 31, 2025, was primarily due to higher Inventories and Other current assets, partially offset by higher Short-term debt, Other current liabilities, and Trade accounts payable balances, as further described in the Liquidity and Capital Resources section below.

Consolidated Results of Operations

Three Months Ended September 30,Nine Months Ended September 30,
20262025% Change20262025% Change
Net sales$23,804$22,1557%$69,706$46,56750%
Cost of goods sold(22,472)(21,092)7%(65,927)(44,169)49%
Gross profit1,3321,06325%3,7792,39858%
Selling, general and administrative expenses(605)(678)(11)%(1,742)(1,476)18%
Interest income2057(65)%108162(33)%
Interest expense(208)(202)3%(586)(412)42%
Foreign exchange gains (losses) – net(63)(55)15%(183)14(1,407)%
Other income (expense) – net1777(78)%109346(68)%
Income (loss) from affiliates228175%3416113%
Income (loss) before income tax51527091%1,5191,04845%
Income tax (expense) benefit(168)(86)95%(390)(290)34%
Income (loss) from continuing operations34718489%1,12975849%
Income (loss) from discontinued operations, net of tax—(3)(100)%—(3)(100)%
Net income (loss)34718192%1,12975550%
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests(29)(15)93%(65)(34)91%
Net income (loss) attributable to Bunge shareholders$318$16692%$1,064$72148%

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

Net sales – Net sales increased 7%, to $23,804 million for the three months ended September 30, 2026. See Reportable Segments section below for further discussion.

Cost of goods sold - Cost of goods sold increased 7%, to $22,472 million for the three months ended September 30, 2026. The increase in Cost of goods sold was primarily due to higher Net sales, as well as current period charges related to the announced sale of two sugarcane mills in Brazil, which included $66 million of impairment charges and $16 million of hedge losses (see Note 2 - Acquisitions and Dispositions to our condensed consolidated financial statements), and $10 million of charges related to losses from inventory damage sustained in relation to the Ukraine-Russia war. The increases were partially offset by more favorable mark-to-market results in the current period.

Selling, general, and administrative expenses - Selling, general, and administrative expenses decreased 11%, to $605 million for the three months ended September 30, 2026. The decrease is primarily due to lower acquisition and integration costs associated with the Viterra Acquisition.

Interest - Interest income decreased 65%, to $20 million for the three months ended September 30, 2026. Interest expense increased 3%, to $208 million for the three months ended September 30, 2026. Lower Interest income is the result of lower average balances in Cash and cash equivalents, as well as lower balances in marketable securities and other short-term investments due to funding strategies in Argentina in the prior year. Higher Interest expense is a result of higher debt levels, driven by higher working capital requirements, partially offset by lower average interest rates.

Foreign exchange gains (losses) – net - Foreign exchange gains (losses) – net increased 15%, to a loss of $63 million for the three months ended September 30, 2026 from a loss of $55 million for the three months ended September 30, 2025. The net loss in the current quarter primarily reflects the impact of hedging costs attributable to monetary assets in South America and losses on U.S. dollar-denominated loans payable in non-U.S. dollar functional currency operations.

Other income (expense) - net - Other income (expense) - net decreased 78%, to $17 million for the three months ended September 30, 2026. The decrease was primarily due to lower gains in Argentina related to foreign currency positioning compared to the prior year.

Income tax (expense) benefit - Income tax (expense) benefit increased 95%, to an income tax expense of $168 million for the three months ended September 30, 2026. The increase in income tax expense for the three months ended September 30, 2026 was primarily due to higher pre-tax income in 2026. Income tax expense for the three months ended September 30, 2026 included the recognition of a deferred tax valuation allowance resulting from the Ukraine-Russia war.

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

Net sales – Net sales increased 50%, to $69,706 million for the nine months ended September 30, 2026. See Reportable Segments section below for further discussion.

Cost of goods sold - Cost of goods sold increased 49%, to $65,927 million for the nine months ended September 30, 2026. The increase in Cost of goods sold was primarily due to higher Net sales, as well as current period charges related to the announced sale of two sugarcane mills in Brazil, which included $66 million of impairment charges and $16 million of hedge losses (see Note 2 - Acquisitions and Dispositions to our condensed consolidated financial statements), and $10 million of charges related to losses from inventory damage sustained in relation to the Ukraine-Russia war. The increases were partially offset by favorable mark-to-market results in the current period.

Selling, general, and administrative expenses - Selling, general, and administrative expenses increased 18%, to $1,742 million for the nine months ended September 30, 2026. The increase is primarily due to increased labor costs as a result of the Viterra Acquisition, partially offset by lower acquisition and integration costs associated with the Viterra Acquisition.

Interest - Interest income decreased 33%, to $108 million for the nine months ended September 30, 2026. Interest expense increased 42%, to $586 million for the nine months ended September 30, 2026. Lower Interest income is the result of lower average balances in Cash and cash equivalents. Higher Interest expense is a result of higher debt levels, driven by the financing of the Viterra Acquisition and higher working capital requirements, partially offset by lower average interest rates.

Foreign exchange gains (losses) – net - Foreign exchange gains (losses) – net decreased 1,407%, to a loss of $183 million for the nine months ended September 30, 2026 from a gain of $14 million for the nine months ended September 30, 2025. The net loss in the current period primarily reflects the impact of hedging costs attributable to monetary assets in South America, as well as additional losses in South America on net monetary assets due to a weaker U.S. dollar. These losses are partially offset by gains on U.S. dollar-denominated loans payable in non-U.S. dollar functional currency operations.

Other income (expense) - net - Other income (expense) - net decreased 68%, to a gain of $109 million for the nine months ended September 30, 2026. The decrease was primarily due to the absence of a $155 million prior year gain on the sale of Bunge's North America corn milling business recognized in the second quarter of 2025, as well as lower gains in Argentina related to foreign currency positioning compared to the prior year.

Income tax (expense) benefit - Income tax (expense) benefit increased 34%, to an income tax expense of $390 million for the nine months ended September 30, 2026. The increase in income tax expense for the nine months ended September 30, 2026 was primarily due to higher pre-tax income in 2026. Income tax expense for the nine months ended September 30, 2026 included the recognition of a deferred tax valuation allowance resulting from the Ukraine-Russia war.

Segment Overview

During the first quarter of 2026, the Other Oilseeds Processing and Refining segment was renamed to Tropical Oils and Specialty Ingredients. The segment name change had no impact on the composition of the Company’s existing four reportable segments, nor did it affect the Company’s previously reported segment results or the consolidated financial statements. See Note 19 - Segment Information to our condensed consolidated financial statements.

Our operations are organized, managed and classified into four reportable segments based upon their similar economic characteristics, nature of products and services offered, production processes, types and classes of customer, and distribution methods. Reportable operations comprise our Soybean Processing and Refining, Softseed Processing and Refining, Tropical Oils and Specialty Ingredients, and Grain Merchandising and Milling reportable segments.

Our remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other. Corporate and Other includes salaries and overhead for corporate functions, including acquisition and integration costs related to the Viterra Acquisition, that are not allocated to our individual reportable segments because the operating performance of each reportable segment is evaluated by the Company’s chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company’s captive insurance activities, accounts receivable securitization activities, and certain income tax assets and liabilities.

A reconciliation of Net income (loss) attributable to Bunge shareholders to Total EBIT follows:

Three Months Ended September 30,Nine Months Ended September 30,
(US$ in millions)2026202520262025
Net income (loss) attributable to Bunge shareholders$318$166$1,064$721
Interest income(20)(57)(108)(162)
Interest expense208202586412
Income tax expense (benefit)16886390290
Income (loss) from discontinued operations, net of tax—3—3
Noncontrolling interests' share of interest and tax(7)3(21)5
Total EBIT$667$403$1,911$1,269
Soybean Processing and Refining5473371,5601,068
Softseed Processing and Refining353236702337
Tropical Oils and Specialty Ingredients13779972
Grain Merchandising and Milling(74)2123254
Segment EBIT8396712,3841,731
Corporate and Other EBIT(172)(268)(473)(462)
Total EBIT$667$403$1,911$1,269

Reportable Segments

Soybean Processing and Refining

Three Months Ended September 30,Nine Months Ended September 30,
(US$ in millions, except volumes)20262025% Change20262025% Change
Volumes (in thousand metric tons)
Soybeans processed11,74512,139(3)%34,02629,55315%
Soybeans merchandised5,2747,246(27)%18,45313,57736%
Refined soy oil production1,05193213%2,8412,6935%
Net sales$11,442$10,8575%$33,065$25,26831%
Cost of goods sold(10,646)(10,359)3%(30,817)(23,877)29%
Selling, general and administrative expenses(174)(143)22%(481)(365)32%
Foreign exchange (losses) gains – net(42)(42)—%(142)9(1,678)%
EBIT attributable to noncontrolling interests(31)(3)933%(65)(13)400%
Other income (expense) – net(12)21(157)%(15)27(156)%
Income (loss) from affiliates10667%1519(21)%
Total Soybean Processing and Refining Segment EBIT$547$33762%$1,560$1,06846%

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

Soybean Processing and Refining segment Net sales increased 5%, to $11,442 million for the three months ended September 30, 2026. The increase was primarily due to higher prices in most regions due to strong global demand driven by biofuel mandates in North America, the conflict with Iran, and tensions in the Black Sea as a result of the Ukraine-Russia war. The increase was partially offset by lower processed volumes in Argentina and lower oilseeds merchandised in our global soybean distribution business partially due to a more normalized export environment in Argentina compared to the prior year.

Segment EBIT increased 62%, to $547 million for the three months ended September 30, 2026. The increase was primarily driven by higher results in most regions in our processing businesses due to a more favorable processing environment and more favorable mark-to-market results.

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

Soybean Processing and Refining segment Net sales increased 31%, to $33,065 million for the nine months ended September 30, 2026. The increase was primarily due to Net sales contributions from the Acquisition of Viterra, as well as higher prices in most regions due to strong global demand driven by biofuel mandates in North America, the conflict with Iran, and tensions in the Black Sea as a result of the Ukraine-Russia war. Volumes are relatively stable compared to the prior period in the legacy businesses.

Segment EBIT increased 46%, to $1,560 million for the nine months ended September 30, 2026. The increase was primarily driven by higher results in all regions in our processing businesses due to a more favorable processing environment. The current period results are partially offset by foreign currency losses recognized in the current year on remeasurement of foreign denominated balances in South America, as well as higher Selling, general and administrative expenses in the current period as a result of the Viterra Acquisition.

Softseed Processing and Refining

Three Months Ended September 30,Nine Months Ended September 30,
(US$ in millions, except volumes)20262025% Change20262025% Change
Volumes (in thousand metric tons)
Softseeds processed3,6063,12915%10,3777,27043%
Softseeds merchandised7431,032(28)%3,4451,142202%
Refined softseed oil production87271123%2,6192,10225%
Net sales$4,302$3,66118%$12,301$6,70783%
Cost of goods sold(3,865)(3,372)15%(11,428)(6,264)82%
Selling, general and administrative expenses(70)(58)21%(194)(131)48%
Foreign exchange (losses) gains – net(8)11(173)%4043(7)%
EBIT attributable to noncontrolling interests—(1)(100)%(3)(2)50%
Other income (expense) – net(4)(5)(20)%(10)(10)—%
Income (loss) from affiliates(2)—100%(4)(6)(33)%
Total Softseed Processing and Refining Segment EBIT$353$23650%$702$337108%

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

Softseed Processing and Refining segment Net sales increased 18%, to $4,302 million for the three months ended September 30, 2026. The increase was primarily due to higher processed volumes in all regions due to a more favorable processing environment, as well as higher volumes in Europe due to activity in Ukraine as a result of the acquisition of an oilseed crush facility from Varthomio completed in the fourth quarter of 2025. The increase was also attributable to higher average sales prices driven by strong demand from global biofuel mandates, a tighter global supply following limited crop availability in Europe and the Black Sea due to the Ukraine-Russia war, elevated global energy prices as a result of the conflict with Iran, and sustained export meal and seeds demand.

Segment EBIT increased 50%, to $353 million for the three months ended September 30, 2026. The increase was primarily due to improved results in North America due to strong demand that drove higher prices as described above, as well as favorable mark-to-market results in the current period. The increase was partially offset by $10 million of charges resulting from the Ukraine-Russia war, primarily related to losses from inventory damage.

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

Softseed Processing and Refining segment Net sales increased 83%, to $12,301 million for the nine months ended September 30, 2026. The increase was primarily due to Net sales contributions from the Acquisition of Viterra, as well as higher average sales prices driven by strong demand from global biofuel mandates, a tighter global supply following limited crop availability in Europe and the Black Sea due to the Ukraine-Russia war, elevated global energy prices as a result of the conflict with Iran, and sustained export meal and seeds demand. Softseeds processed were also higher in all regions due to a more favorable processing environment, as well as higher volumes in Europe due to activity in Ukraine as a result of the acquisition of an oilseed crush facility from Varthomio completed in the fourth quarter of 2025.

Segment EBIT increased 108%, to $702 million for the nine months ended September 30, 2026. The increase was primarily due to improved results across all regions due to a more favorable processing environment supported by strong demand and tighter global supply described above. The increase was partially offset by less favorable mark-to-market results in the current period and $10 million of charges resulting from the Ukraine-Russia war, primarily related to losses from inventory damage.

Tropical Oils and Specialty Ingredients

Three Months Ended September 30,Nine Months Ended September 30,
(US$ in millions, except volumes)20262025% Change20262025% Change
Volumes (in thousand metric tons)6746395%1,9731,8815%
Net sales$1,295$1,2077%$3,782$3,44210%
Cost of goods sold(1,220)(1,063)15%(3,481)(3,174)10%
Selling, general and administrative expenses(59)(57)4%(180)(176)2%
Foreign exchange (losses) gains – net—(2)100%(4)(5)(20)%
EBIT attributable to noncontrolling interests(1)(8)(88)%(12)(10)20%
Other income (expense) – net(2)—100%(6)(5)20%
Total Tropical Oils and Specialty Ingredients Segment EBIT$13$77(83)%$99$7238%

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

Tropical Oils and Specialty Ingredients segment Net sales increased 7%, to $1,295 million for the three months ended September 30, 2026. The increase was primarily due to higher volumes in our tropical oils business, as well as higher volumes in our proteins business driven by the opening of our production facility in the United States and the acquisition of certain businesses of International Flavors and Fragrances, Inc. ("IFF") in the first quarter of 2026 (see Note 2 - Acquisitions and Dispositions to our condensed consolidated financial statements). Prices were also higher driven by higher commodity prices due to stronger vegetable oil demand, global biofuel mandates, and the conflict with Iran.

Segment EBIT decreased 83%, to $13 million for the three months ended September 30, 2026. The decrease was primarily due to lower results in our tropical oils business driven by less favorable mark-to-market results relative to the prior year as well as current period margin impacts associated with geopolitical trade disruptions.

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

Tropical Oils and Specialty Ingredients segment Net sales increased 10%, to $3,782 million for the nine months ended September 30, 2026. The increase was primarily due to higher volumes in our tropical oils business, as well as higher volumes in our proteins business following the opening of our production facility in the United States and the acquisition of certain businesses of IFF in the first quarter of 2026 (see Note 2 - Acquisitions and Dispositions to our condensed consolidated financial statements). The increase was also due to higher sales prices in our tropical oils business driven by higher commodity prices due to stronger vegetable oil demand, global biofuel mandates, and the conflict with Iran.

Segment EBIT increased 38%, to $99 million for the nine months ended September 30, 2026. The increase was primarily due to higher results in our tropical oils business due to higher Net sales described above, as well as more favorable mark-to-market results relative to the prior year, partially offset by lower margins as a result of commissioning, ramp-up, and plant transition costs related to both our tropical oils and proteins businesses.

Grain Merchandising and Milling

Three Months Ended September 30,Nine Months Ended September 30,
(US$ in millions)20262025% Change20262025% Change
Volumes (in thousand metric tons)23,80624,080(1)%74,21640,97281%
Net sales$6,764$6,4285%$20,555$11,14684%
Cost of goods sold(6,714)(6,285)7%(20,171)(10,845)86%
Selling, general and administrative expenses(133)(145)(8)%(389)(266)46%
Foreign exchange (losses) gains – net(19)(15)27%(75)(41)83%
EBIT attributable to noncontrolling interests(6)(1)500%(9)(6)50%
Other income (expense) – net2137(43)%88263(67)%
Income (loss) from affiliates132550%243700%
Total Grain Merchandising and Milling Segment EBIT$(74)$21(452)%$23$254(91)%

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

Grain Merchandising and Milling segment Net sales increased 5%, to $6,764 million for the three months ended September 30, 2026. The increase was primarily due to higher average sales prices in our global corn and wheat businesses as a result of global supply concerns from factors such as tensions in the Black Sea resulting from the Ukraine-Russia war and a smaller crop in North America, as well as higher volumes in our global cotton and South American wheat milling businesses. The increases were partially offset by lower volumes in our global corn business due to decreased demand.

Segment EBIT decreased 452%, to a loss of $74 million for the three months ended September 30, 2026. The decrease was primarily due to charges related to the announced sale of two sugarcane mills in Brazil, which included $66 million of impairment charges and $16 million of hedge losses, as well as lower results in our ocean freight business due to unfavorable timing of vessel-related costs in the current year. The decreases were partially offset by more favorable mark-to-market results in certain other business.

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

Grain Merchandising and Milling segment Net sales increased 84%, to $20,555 million for the nine months ended September 30, 2026. The increase was primarily due to Net sales contributions from the Acquisition of Viterra. In addition, prices in our global corn and wheat businesses increased as a result of global supply concerns from factors such as tensions in the Black Sea resulting from the Ukraine-Russia war and a smaller crop in North America. Volumes were also higher in our global corn and wheat businesses, as well as our South American wheat milling business. The above increases were partially offset by the lack of recurring sales in the first half of the year from our North American corn milling business that was divested in the second quarter of 2025.

Segment EBIT decreased 91%, to $23 million for the nine months ended September 30, 2026. The decrease was primarily due to the absence of a prior year $155 million gain on the sale of Bunge's North America corn milling business recognized in the second quarter of 2025, higher Selling, general and administrative expenses in the current period as a result of the Viterra Acquisition, and charges related to the announced sale of two sugarcane mills in Brazil, which included $66 million of impairment charges and $16 million of hedge losses (see Note 2 - Acquisitions and Dispositions to our condensed consolidated financial statements). The decrease was partially offset by more favorable results driven by contributions from the Acquisition of Viterra, the financial services business, and our South American wheat milling business.

Corporate and Other

Three Months Ended September 30,Nine Months Ended September 30,
(US$ in millions)20262025% Change20262025% Change
Net sales$1$2(50)%$3$4(25)%
Cost of goods sold(27)(13)108%(30)(9)233%
Selling, general and administrative expenses(169)(275)(39)%(498)(538)(7)%
Foreign exchange (losses) gains – net6(7)186%(2)8(125)%
EBIT attributable to noncontrolling interests21100%3250%
Other income (expense) – net1424(42)%5271(27)%
Income (loss) from affiliates1—100%(1)—(100)%
Total Corporate and Other EBIT$(172)$(268)36%$(473)$(462)(2)%

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

Corporate and Other EBIT increased 36%, to a loss of $172 million for the three months ended September 30, 2026. The increase was primarily driven by a decrease in Selling, general and administrative expenses as a result of lower acquisition and integration costs in the current year associated with the Viterra Acquisition as well as lower performance-based compensation expenses. The Company recognized acquisition and integration costs within Corporate and Other EBIT of $21 million, and $101 million for the three months ended September 30, 2026 and September 30, 2025, respectively.

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

Corporate and Other EBIT decreased 2%, to a loss of $473 million for the nine months ended September 30, 2026. The decrease was primarily due to an increase in Cost of goods sold as a result of losses in our captive insurance program, as well as lower Other income (expense) - net. The decrease was partially offset by a decrease in Selling, general and administrative expenses as a result of lower acquisition and integration costs in the current year associated with the Viterra Acquisition. The Company recognized acquisition and integration costs within Corporate and Other EBIT of $91 million and $171 million for the nine months ended September 30, 2026 and September 30, 2025, respectively.

Liquidity and Capital Resources

Our main financial objectives are to prudently manage financial risks, ensure consistent access to liquidity and minimize cost of capital in order to efficiently finance our business and maintain balance sheet strength. We generally finance our ongoing operations with cash flows generated from operations, issuances of commercial paper, borrowings under various bilateral and syndicated revolving credit facilities, term loans, and proceeds from the issuance of senior notes. Acquisitions and long-lived assets are generally financed with a combination of equity and long-term debt.

Working Capital

As of
(US$ in millions, except current ratio)September 30, 2026December 31, 2025September 30, 2025
Cash and cash equivalents$524$1,135$1,315
Trade accounts receivable, net4,1373,8703,494
Inventories16,62413,19813,312
Other current assets (1)7,9246,1888,598
Total current assets$29,209$24,391$26,719
Short-term debt$6,471$3,883$4,446
Current portion of long-term debt1,3311,3371,334
Trade accounts payable5,5764,8814,780
Current operating lease obligations480499491
Other current liabilities (2)5,5774,5275,046
Total current liabilities$19,435$15,127$16,097
Working capital (3)$9,774$9,264$10,622
Current ratio (3)1.501.611.66

(1) Comprises Time deposits under trade structured finance program, Assets held for sale, and Other current assets

(2) Comprises Letter of credit obligations under trade structured finance program, Liabilities held for sale, and Other current liabilities

(3) Working capital is defined as Total current assets less Total current liabilities; Current ratio represents Total current assets divided by Total current liabilities

Working capital was $9,774 million at September 30, 2026, an increase of $510 million from working capital of $9,264 million at December 31, 2025, and a decrease of $848 million from working capital of $10,622 million at September 30, 2025.

Cash and Cash Equivalents - Cash and cash equivalents were $524 million at September 30, 2026, a decrease of $611 million from $1,135 million at December 31, 2025, and a decrease of $791 million from $1,315 million at September 30, 2025. Cash balances are managed in accordance with our investment policy, the objectives of which are to preserve the principal value of our cash assets, maintain a high degree of liquidity, and deliver competitive returns subject to prevailing market conditions. Cash balances are typically invested in short-term deposits, money market funds, commercial paper programs with highly rated institutions, and in U.S. government securities. Please refer to the Cash Flows section of this report, below, for further details regarding the factors giving rise to the change in Cash and cash equivalents during the nine months ended September 30, 2026.

Trade accounts receivable, net - Trade accounts receivable, net were $4,137 million at September 30, 2026, an increase of $267 million from $3,870 million at December 31, 2025, and an increase of $643 million from $3,494 million at September 30, 2025. The increases from December 31, 2025 and September 30, 2025 were primarily due to higher average sales prices driven by factors described in the Segment Overview section above, which were partially offset by higher receivables sold into our securitization program.

Inventories - Inventories were $16,624 million at September 30, 2026, an increase of $3,426 million from $13,198 million at December 31, 2025, and an increase of $3,312 million from $13,312 million at September 30, 2025. The increase from December 31, 2025 was primarily due to increased soybean volumes in conjunction with the timing of the South

American harvest, as well as higher prices on most commodities, partially offset by decreased volumes for certain commodities. The increase from September 30, 2025 was primarily due to higher average prices on most commodities, partially offset by decreased volumes for certain commodities.

RMI comprise agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, corn, softseeds, softseed oil, and wheat that are readily convertible to cash because of their commodity characteristics, widely available markets and international pricing mechanisms. Total RMI reported at fair value was $14,696 million, $11,361 million, and $11,514 million at September 30, 2026, December 31, 2025, and September 30, 2025, respectively (see Note 5 - Inventories to our condensed consolidated financial statements).

Other current assets - Other current assets were $7,924 million at September 30, 2026, an increase of $1,736 million from $6,188 million at December 31, 2025, and a decrease of $674 million from $8,598 million at September 30, 2025. The increase from December 31, 2025 was attributable to an increase in unrealized gains on derivative contracts at fair value as a result of volatile commodity prices and exchange rate fluctuations, an increase in Assets held for sale primarily related to the announced sale of our two sugarcane mills in Brazil (see Note 2 - Acquisitions and Dispositions to our condensed consolidated financial statements), an increase in margin deposits, and an increase in prepaid commodity purchase contracts in conjunction with the timing of the South American harvest. These increases were partially offset by a reduction in marketable securities and other short-term investments based on dynamic investment strategies in South America, the reduction of time deposits under the trade structured finance program, and the collection of our $80 million disposition receivable resulting from the sale of 40% of our Spanish operating subsidiary. The decrease from September 30, 2025 was attributable to a reduction in marketable securities and other short-term investments based on dynamic investment strategies in South America, a reduction in time deposits under the trade structured finance program, and the collection of our $80 million disposition receivable as noted above. The decreases were partially offset by an increase in margin deposits, an increase in unrealized gains on derivative contracts at fair value as a result of volatile commodity prices and exchange rate fluctuations, and an increase in Assets held for sale primarily related to the announced sale of our two sugarcane mills in Brazil as noted above.

Short-term debt - Short-term debt, including the Current portion of long-term debt, was $7,802 million at September 30, 2026, an increase of $2,582 million from $5,220 million at December 31, 2025, and an increase of $2,022 million from $5,780 million at September 30, 2025. The higher short-term debt level at September 30, 2026, compared to December 31, 2025 was due to higher borrowings by Bunge under its commercial paper program and revolving credit facilities to fund higher working capital requirements. The increase from September 30, 2025 was due to higher borrowings by Bunge under its revolving credit facilities and higher borrowings under bilateral short-term credit lines entered into through our financing subsidiaries to fund working capital requirements, partially offset by lower borrowings under the commercial paper program. The Current portion of long-term debt remained relatively unchanged at September 30, 2026 compared to December 31, 2025 and September 30, 2025 as the repayments of the 2.00% Senior Notes due 2026 and 3.25% Senior Notes due 2026 upon their respective maturities in April and August 2026, were offset by two tranches of senior notes due in 2027 and the $250 million term loan due 2027 in the current period.

Trade accounts payable - Trade accounts payable were $5,576 million at September 30, 2026, an increase of $695 million from $4,881 million at December 31, 2025, and an increase of $796 million from $4,780 million at September 30, 2025. The increase from December 31, 2025 was primarily due to higher inventory volumes in conjunction with the South American harvest and higher average commodity prices. The increase from September 30, 2025 was primarily due to higher average commodity prices in the current period.

Other current liabilities - Other current liabilities were $5,577 million at September 30, 2026, an increase of $1,050 million from $4,527 million at December 31, 2025, and an increase of $531 million from $5,046 million at September 30, 2025. The increase from December 31, 2025 and September 30, 2025 was primarily due to an increase in unrealized losses on derivative contracts as a result of volatile commodity prices and higher Liabilities held for sale related to the announced sale of our two sugarcane mills in Brazil (see Note 2 - Acquisitions and Dispositions to our condensed consolidated financial statements), partially offset by lower letter of credit obligations under the trade structured finance program. Additionally, the increase from December 31, 2025 is partially offset by lower advances on sales driven by timing of receipts in North America.

Debt

As highlighted in Note 13 - Debt and discussed further below, we utilize a variety of debt financing structures to maintain financial flexibility to meet our various financial objectives.

Revolving Credit Facilities — At September 30, 2026, we had $8,515 million unused and available committed borrowing capacity, comprised of committed revolving credit facilities. The following table summarizes these facilities as of the periods presented:

(US$ in millions)Committed CapacityBorrowings Outstanding
Revolving Credit FacilitiesMaturities (1)September 30, 2026September 30, 2026December 31, 2025
$1.1 Billion 364-Day Revolving Credit Agreement2026$1,100$—$—
$3.5 Billion Revolving Facility Agreement20283,5001,150600
$4.2 Billion Revolving Credit Agreement20304,200——
$865 Million Revolving Credit Agreement2030865——
Total Revolving Credit Facilities$9,665$1,150$600

(1)See Note 13 - Debt to our condensed consolidated financial statements for a description of current period activity related to these facilities, including October 2026 actions resulting in extended maturities.

Commercial Paper Program - The following table summarizes the facility as of the periods presented:

(US$ in millions)Program CapacityBorrowings Outstanding
Commercial Paper Program (1)September 30, 2026September 30, 2026December 31, 2025
$3 Billion Commercial Paper Program$3,000$2,073$300

(1)The short-term credit ratings of the commercial paper program require Bunge to keep same day unused committed borrowing capacity under its long-term committed credit facilities in an amount greater or equal to the amount of commercial paper issued and outstanding.

Short and long-term debt —

As of
US$ in millionsSeptember 30, 2026September 30, 2025December 31, 2025
Short-term debt$6,471$4,446$3,883
Long-term debt, including current portion10,27511,14310,168
Total debt$16,746$15,589$14,051
Nine Months Ended September 30, 2026Nine Months Ended September 30, 2025Year Ended December 31, 2025
Average total debt outstanding$15,332$10,025$11,153

Our total debt was $16,746 million at September 30, 2026, an increase of $2,695 million from $14,051 million at December 31, 2025, and an increase of $1,157 million from $15,589 million at September 30, 2025. The higher total debt level at September 30, 2026, compared to December 31, 2025 was primarily due to an increase in short-term borrowings as described above and an increase in long-term debt, including current portion, due to the issuance of two tranches of senior notes for an aggregate principal amount of $1.2 billion in March 2026, and the issuance of $600 million senior notes in August 2026 (collectively, the "2026 Senior Notes"), partially offset by repayment of the 2.00% Senior Notes due 2026 and 3.25% Senior Notes due 2026 upon their respective maturities in April and August 2026. The higher total debt levels compared to September 30, 2025 were due to an increase in short-term borrowings as described above. The increase was partially offset by a decrease in long-term debt, including current portion, due the repayment of $1.0 billion in term loans, and the repayments of the 2.00% Senior Notes due 2026 and 3.25% Senior Notes due 2026 upon their respective maturities described above. These decreases were partially offset by the issuance of the 2026 Senior Notes. See Note 13 - Debt to our condensed consolidated financial statements for further information.

From time to time, through our financing subsidiaries, we enter into bilateral short-term credit lines as necessary. There were $880 million, $900 million, and $100 million borrowings outstanding under these bilateral short-term credit lines at September 30, 2026, December 31, 2025, and September 30, 2025, respectively. The increase compared to September 30, 2025 is primarily to support working capital requirements.

In addition, Bunge's operating companies had $2,368 million, $2,083 million, and $2,051 million in short-term borrowings outstanding from local bank facilities at September 30, 2026, December 31, 2025, and September 30, 2025, respectively, to support working capital requirements.

Registered Senior Notes — BLFC, a wholly owned finance subsidiary of Bunge, had the following outstanding debt securities (collectively referred to as the "BLFC Notes") registered under the requirements of the Securities Act of 1933, as amended, at September 30, 2026.

(US$ in millions)Aggregate Principal Amount OutstandingBalance Outstanding
4.90% Senior Notes due 2027$440$441
3.75% Senior Notes due 2027600599
4.10% Senior Notes due 2028400399
4.20% Senior Notes due 2029800795
4.55% Senior Notes due 2030650646
3.20% Senior Notes due 2031599563
2.75% Senior Notes due 20311,000995
5.00% Senior Notes due 2031600594
5.25% Senior Notes due 2032300306
4.80% Senior Notes due 2033500496
4.65% Senior Notes due 2034800792
5.15% Senior Notes due 2035650644
5.15% Senior Notes due 2036700694

Bunge unconditionally guarantees BLFC's obligations with respect to the BLFC Notes. Bunge's guarantees are unsecured and unsubordinated obligations of Bunge and rank equally with all other unsecured and unsubordinated obligations of Bunge. The guarantees provide that in the event of a default in payment of principal of, or interest on, BLFC Notes of a particular series, the holder of such series of senior debt securities may institute legal proceedings directly against Bunge to enforce the applicable guarantee without first proceeding against BLFC.

As a holding company, Bunge is dependent upon dividends, loans, or advances or other intercompany transfers of funds from its subsidiaries to meet its obligations, including its obligations under the guarantee. The ability of certain of its subsidiaries to pay dividends and make other payments to Bunge may be restricted by, among other things, applicable laws, as well as agreements to which those subsidiaries may be party. Therefore, the ability of Bunge to make payments with respect to the guarantee may be limited. The BLFC Notes effectively rank junior to all liabilities of Bunge's subsidiaries (other than BLFC). In the event of a bankruptcy, liquidation, or dissolution of a subsidiary (other than BLFC) and following payment of its liabilities, the subsidiary may not have sufficient assets remaining to make payments to Bunge as a shareholder or otherwise.

Credit Ratings — Bunge’s debt ratings and outlook by major credit rating agencies at September 30, 2026, were as follows:

Short-term Debt (1)Long-term DebtOutlook
Standard & Poor’sA-2A-Stable
Moody’sP-2Baa1Stable
FitchF-2BBB+Stable

(1) Short-term debt rating applies only to the commercial paper program with BLFC as the issuer.

Our debt agreements do not have any credit rating downgrade triggers that would accelerate maturity of our debt. However, credit rating downgrades would increase borrowing costs under our syndicated credit facilities (a credit rating upgrade, on the other hand, would reduce our borrowing cost) and, depending on their severity, could impede our ability to obtain credit facilities or access the capital markets in the future on competitive terms. A significant increase in our borrowing costs could impair our ability to compete effectively in our business relative to competitors with higher credit ratings.

Our credit facilities and certain senior notes require us to comply with specified financial and non-financial covenants including a maximum debt to capitalization ratio, as well as limitations related to incurring liens and secured indebtedness. We were in compliance with these covenants as of September 30, 2026.

Equity

Total equity is set forth in the following table:

(US$ in millions)September 30, 2026December 31, 2025
Registered shares$2$2
Additional paid-in capital9,8519,841
Retained earnings13,65713,152
Accumulated other comprehensive income (loss)(6,005)(6,084)
Treasury shares, at cost(1,209)(1,007)
Total Bunge shareholders’ equity16,29615,904
Noncontrolling interest1,5061,465
Total equity$17,802$17,369

Total Bunge shareholders’ equity was $16,296 million at September 30, 2026, compared to $15,904 million at December 31, 2025, an increase of $392 million. The increase was primarily due to $1,064 million of Net income (loss) attributable to Bunge and $79 million of income in Other comprehensive income (loss) resulting from favorable foreign exchange translation adjustments. These increases were partially offset by $555 million of declared dividends to shareholders and $249 million of share repurchases, as described in Note 17 - Equity to our condensed consolidated financial statements.

Noncontrolling interests increased to $1,506 million at September 30, 2026, from $1,465 million at December 31, 2025, primarily due to $120 million in capital contributions received from minority interest stakeholders and $39 million of net income (loss) attributable to noncontrolling interests, partially offset by measurement period adjustments of $101 million in connection with noncontrolling interests recognized from the Acquisition of Viterra.

Share repurchase program - As described in Note 17 - Equity to our condensed consolidated financial statements, there were aggregate remaining purchase authorizations of $3.0 billion as of September 30, 2026 under approved share repurchase programs. During the three months ended September 30, 2026, Bunge did not repurchase any shares. During the nine months ended September 30, 2026, Bunge repurchased 1,966,107 registered shares for $249 million, completing share repurchases under a previously existing program.

Cash Flows

Nine Months Ended September 30,
(US$ in millions)20262025
Cash provided by (used for) operating activities$(2,302)$(503)
Cash provided by (used for) investing activities(840)(5,524)
Cash provided by (used for) financing activities2,5374,021
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale133
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale$(592)$(2,003)

Our cash flows from operations vary depending on, among other items, Net income and the market prices and timing of purchase and sale of our inventories. Generally, during periods when commodity prices are rising, our agribusiness operations require increased use of cash to support working capital to acquire inventories and fund daily settlement requirements on exchange traded futures that we use to minimize price risk related to purchases and sales of our inventories.

During the nine months ended September 30, 2026, our cash and cash equivalents, restricted cash, and cash held for sale decreased by $592 million, compared to a decrease of $2,003 million during the nine months ended September 30, 2025, as further explained below.

Operating: Cash used for operating activities was $2,302 million for the nine months ended September 30, 2026, an increase of $1,799 million, compared to cash used for operating activities of $503 million for the nine months ended September 30, 2025. The increase in cash used for operations was primarily driven by net changes in working capital, partially offset by higher reported net income during the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 as discussed in the Segment Overview and Consolidated Results of Operations sections above, as well as a large adjustment for non-cash depreciation as a result of the Acquisition of Viterra.

Certain of our non-U.S. operating subsidiaries are primarily funded with U.S. dollar-denominated debt, while currency risk is hedged with U.S. dollar-denominated assets. The functional currency of our operating subsidiaries is generally the local currency. The financial statements of our subsidiaries are calculated in the functional currency, and when the local currency is the functional currency, translated into U.S. dollars. U.S. dollar-denominated loans are remeasured into their respective functional currencies at exchange rates at the applicable balance sheet date. Also, certain of our U.S. dollar functional operating subsidiaries outside the U.S. are partially funded with local currency borrowings, while the currency risk is hedged with local currency denominated assets. Local currency loans in U.S. dollar functional currency subsidiaries outside the U.S. are remeasured into U.S. dollars at the exchange rate on the applicable balance sheet date. The resulting gain or loss is included in our condensed consolidated statements of income as Foreign exchange gains (losses) – net. For the nine months ended September 30, 2026, we recorded a foreign currency gain on our debt of $87 million, which was included as an adjustment to reconcile Net income to Cash provided by (used for) operating activities in the line item Foreign exchange (gain) loss on net debt in our condensed consolidated statements of cash flows. These adjustments are required as the gains and losses are non-cash items that arise from financing activities and therefore will have no impact on cash flows from operations.

Investing: Cash used for investing activities was $840 million for the nine months ended September 30, 2026, a decrease of $4,684 million, compared to cash used for investing activities of $5,524 million for the nine months ended September 30, 2025. The decrease was primarily related to prior year cash payments of $4,116 million, net of cash acquired, for the Acquisition of Viterra, and decreased payments for certain investment strategies in Argentina. The decrease was partially offset by prior period receipts of $470 million from the sale of Bunge's corn milling business in North America, $457 million related to a European Union oilseeds divestment, and $100 million from the sale of BP Bunge Bioenergia, as well as current period cash payments of $105 million for certain businesses of International Flavors and Fragrances, Inc.

Financing: Cash provided by financing activities was $2,537 million for the nine months ended September 30, 2026, a decrease of $1,484 million, compared to cash provided by financing activities of $4,021 million for the nine months ended September 30, 2025. The decrease was primarily attributable to a decrease in net cash proceeds from short and long-term debt of $1,656 million driven by prior year borrowings to fund the Acquisition of Viterra as well as current period repayments of senior notes due in April and August 2026, partially offset by proceeds from the issuance of the 2026 Senior Notes in the first and third quarters of 2026. Additionally, the decrease is attributable to the difference between $206 million of proceeds received from the sale of a redeemable noncontrolling interest related to our Spanish operating subsidiary in the prior period, compared to $80 million in deferred consideration received from the same sale of redeemable noncontrolling interest in the current period. These decreases were partially offset by share repurchases of $249 million in the current period compared to $545 million in the prior period.

Off-Balance Sheet Arrangements

Please refer to Note 15 - Commitments and Contingencies to our condensed consolidated financial statements for details concerning our off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.

Dividends

We paid a regular quarterly cash dividend distribution of $0.72 per share on September 1, 2026, to shareholders of record on August 18, 2026. On May 20, 2026, shareholders of Bunge Global SA approved a cash dividend distribution in the amount of $2.88 per share, payable in four equal quarterly installments of $0.72 per share beginning in the second quarter of fiscal year 2026 and ending in the first quarter of fiscal year 2027. The $0.72 per share dividend distribution represents a $0.02, or 3% increase from the Company’s previously approved quarterly cash dividend declared of $0.70 per share.

Critical Accounting Policies and Estimates

Critical accounting policies are defined as those policies that are significant to our financial condition and results of operations and require management to exercise significant judgment. For a complete discussion of our accounting policies, see Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission on February 19, 2026. For recent accounting pronouncements refer to Note 1 - Basis of Presentation, Principles of Consolidation, and Significant Accounting Policies, to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

Previous: Item 1. FINANCIAL STATEMENTS · Next: Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK